Exploratory Study of Four Repurposed Anti-Infective Drug Regimens

Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial.

Clinical Infectious Diseases Brief Report
Interest Conference: 9 – 12 May 2023 Maputo, Mozambique

Categories

Archive